Cytokines and related receptor-mediated signaling pathways

Biochemical and Biophysical Research Communications

Volumn 297, Issue 4, 2002, Pages 700-713

  Haddad, John J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Cytokine; Immunopharmacology; Network; Neuroimmunology; Receptor; Transcription factors

Indexed keywords

CYTOKINE;

ARTICLE; BIODIVERSITY; CELL INTERACTION; CELL POPULATION; CELL SECRETION; IMMUNE SYSTEM; INFLAMMATION; INTERPERSONAL COMMUNICATION; MOLECULAR WEIGHT; PHYSIOLOGY; PRIORITY JOURNAL; REDUNDANCY ANALYSIS; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0036029247     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02287-8     Document Type: Review

References (99)

1. L.P. Nicod, Cytokines: overview, Thorax 48 (1993) 660-667.
2. B. Rouveix, Clinical pharmacology of cytokines, Eur. Cytokine Netw. 8 (1997) 291-293.
3. D. Boraschi, M.G. Cifone, W. Falk, H.-D. Flad, A. Tagliabue, M.U. Martin, Cytokines in inflammation, Eur. Cytokine Netw. 9 (1998) 205-212.
4. C.A. Dinarello, Pro-inflammatory cytokines, Chest 118 (2000) 503-508.
5. J.J. Oppenheim, Cytokines: past, present, and future, Int. J. Hematol. 74 (2001) 3-8.
6. A.F. Holloway, S. Rao, M.F. Shannon, Regulation of cytokine gene transcription in the immune system, Mol. Immunol. 38 (2002) 567-580.
7. J.J. Tyson, K. Chen, B. Novak, Network dynamics and cell physiology, Nat. Rev. Mol. Cell. Biol. 2 (2001) 908-916.
8. Feldmann, F.M. Brennan, R.N. Maini, Role of cytokines in rheumatoid arthritis, Annu. Rev. Immunol. 14 (1996) 397-440.
9. D. Maslinska, The cytokine network and interleukin-15 (IL-15) in brain development, Folia Neuropathol. 39 (2001) 43-47.
10. H.J. Deeg, Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction, Int. J. Hematol. 74 (2001) 26-32.
11. L.A. Segel, Controlling the immune system: diffuse feedback via a diffuse informational network, Novartis Found. Symp. 239 (2001) 31-40.
12. M. Akdis, A. Trautmann, S. Klunker, K. Blaser, C.A. Akdis, Cytokine network and dysregulated apoptosis in atopic dermatitis, Acta Odontol. Scand. 59 (2001) 178-182.
13. J. Parkin, B. Cohen, An overview of the immune system, Lancet 357 (2001) 1777-1789.
14. H. Chang, A.L. Lau, M.M. Matzuk, Studying TGF-b superfamily signaling by knockouts and knockins, Mol. Cell. Endocrinol. 180 (2001) 39-46.
15. S. Joyce, Immune recognition, response, and regulation: how T lymphocytes do it, Immunol. Res. 23 (2001) 215-228.
16. B.T. Kile, N.A. Nicola, W.S. Alexander, Negative regulators of cytokine signaling, Int. J. Hematol. 73 (2001) 292-298.
17. C.M. Pastor, J.L. Frossard, Are genetically modified mice useful for the understanding of acute pancreatitis?, FASEB J. 15 (2001) 893-897.
18. C. Yan, M.M. Matzuk, Transgenic models of ovarian failure, J. Soc. Gynecol. Investig. 8 (2001) S30-S33.
19. M. Sato, T. Taniguchi, N. Tanaka, The interferon system and interferon regulatory factor transcription factors: studies from gene knockout mice, Cytokine Growth Factor Rev. 12 (2001) 133-142.
20. J. Hiscott, Introduction: cytokine receptors, signaling pathways, and viruses, Cytokine Growth Factor Rev. 12 (2001) 129-131.
21. A.N. Shakhov, S.A. Nedospasov, Expression profiling in knockout mice: lymphotoxin versus tumor necrosis factor in the maintenance of splenic micro-architecture, Cytokine Growth Factor Rev. 12 (2001) 107-119.
22. C. Gabay, Cytokine inhibitors in the treatment of rheumatoid arthritis, Expert Opin. Biol. Ther. 2 (2002) 135-149.
23. T. van der Poll, E. de Jonge, M. Levi, Regulatory role of cytokines in disseminated intravascular coagulation, Semin. Thromb. Hemost. 27 (2001) 639-651.
24. M.J. Bown, M.L. Nicholson, P.R. Bell, R.D. Sayers, Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair, Eur. J. Vasc. Endovasc. Surg. 22 (2001) 485-495.
25. J.V. Fahy, Remodeling of the airway epithelium in asthma, Am. J. Respir. Crit. Care Med. 164 (2001) S46-S51.
26. H. Tilg, Cytokines and liver diseases, Can. J. Gastroenterol. 15 (2001) 661-668.
27. R. Kurzrock, The role of cytokines in cancer-related fatigue, Cancer 92 (2001) 1684-1688.
28. K. Nakanishi, T. Yoshimoto, H. Tsutsui, H. Okamura, Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu, Cytokine Growth Factor Rev. 12 (2001) 53-72.
29. P.C. Smith, A. Hobisch, D.L. Lin, Z. Culig, E.T. Keller, Interleukin-6 and prostate cancer progression, Cytokine Growth Factor Rev. 12 (2001) 33-40.
30. J. Bauer, H. Rauschka, H. Lassmann, Inflammation in the nervous system: the human perspective, Glia 36 (2001) 235-243.
31. B. Henderson, S. Poole, M. Wilson, Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis, Microbiol. Rev. 60 (1996) 316-341.
32. R.J. Ulevitch, P.S. Tobias, Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin, Annu. Rev. Immunol. 13 (1995) 437-457.
33. D. Hersh, J. Weiss, A. Zychlinsky, How bacteria initiate inflammation: aspects of the emerging story, Curr. Opin. Microbiol. 1 (1998) 43-48.
34. V. Turcanu, N.A. Williams, Cell identification and isolation on the basis of cytokine secretion: a novel tool for investigating immune responses, Nat. Med. 7 (2001) 373-376.
35. M.A. Freudenberg, T. Merlin, M. Gumenscheimer, C. Kalis, R. Landmann, C. Galanos, Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria, Microbes Infect. 3 (2001) 1213-1222.
36. C. Alexander, E.T. Rietschel, Bacterial lipopolysaccharides and innate immunity, J. Endotoxin Res. 7 (2001) 167-202.
37. J. Hawiger, Innate immunity and inflammation: a transcriptional paradigm, Immunol. Res. 23 (2001) 99-109.
38. J. Thorn, The inflammatory response in humans after inhalation of bacterial endotoxin: a review, Inflamm. Res. 50 (2001) 254-261.
39. D.L. Stevens, Superantigens: their role in infectious diseases, Immunol. Invest. 26 (1997) 275-281.
40. J. Schiffenbauer, Superantigens and their role in autoimmune disorders, Arch. Immunol. Ther. Exp. (Warsz.) 47 (1999) 17-24.
41. + regulatory T cells: their role in the control of superantigen responses, Immunol. Rev. 182 (2001) 180-189.
42. D.N. Posnett, A.A. Yarilina, Sleeping with the enemy: endogenous superantigens in humans, Immunity 15 (2001) 503-506.
43. H. Muller-Alouf, C. Carnoy, M. Simonet, J.E. Alouf, Superantigen bacterial toxins: state of the art, Toxicon 39 (2001) 1691-1701.
44. A. Miyajima, T. Kitamura, N. Harada, T. Yokota, K. Arai, Cytokine receptors and signal transduction, Annu. Rev. Immunol. 10 (1992) 295-331.
45. T. Taniguchi, Regulation of cytokine gene expression, Annu. Rev. Immunol. 6 (1988) 439-464.
46. J. Raber, O. Sorg, T.F. Horn, N. Yu, G.F. Koob, I.L. Campbell, F.E. Bloom, Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function, Brain Res. Brain Res. Rev. 26 (1998) 320-326.
47. M. Nesin, S. Cunningham-Rundles, Cytokines and neonates, Am. J. Perinatol. 17 (2000) 393-404.
48. J.C. Weaver, P. McGrath, S. Adams, Gel microdrop technology for rapid isolation of rare and high producer cells, Nat. Med. 3 (1997) 583-585.
49. F. Gray, J.S. Kenney, J.F. Dunne, Secretion capture and report web: use of aRnity derivatized agarose microdroplets for the selection of hybridoma cells, J. Immunol. Methods 182 (1995) 155-163.
50. A. Scheffold, M. Assenmacher, L. Reiners-Schramm, R. Lauster, A. Radbruch, High-sensitivity immunofluorescence for detection of the pro- and anti-inflammatory cytokines γ-interferon and interleukin-10 on surface of cytokine-secreting cells, Nat. Med. 6 (2000) 107-110.
51. J.F. Bazan, Structural design and molecular evolution of a cytokine receptor superfamily, Proc. Natl. Acad. Sci. USA 87 (1990) 6934-6938.
52. S.C. Bischoff, A.L. de Weck, C.A. Dahinden, Peptide analogs of consensus receptor sequence inhibit the action of cytokines on human basophils, Lymphokine Cytokine Res. 11 (1992) 33-37.
53. D. Cosman, S.D. Lyman, R.L. Idzerda, M.P. Beckmann, L.S. Park, R.G. Goodwin, C.J. March, A new cytokine receptor superfamily, Trends Biochem. Sci. 15 (1990) 265-270.
54. R. Fernandez-Botran, Soluble cytokine receptors: their role in immunoregulation, FASEB J. 5 (1991) 2567-2574.
55. T. Kishimoto, T. Taga, S. Akira, Cytokine signal transduction, Cell 76 (1994) 253-262.
56. G. Lutfalla, K. Gardiner, G. Uze, A new member of the cytokine receptor gene family maps on chromosome 21 at less than 35 kb from IFNαR, Genomics 16 (1993) 366-373.
57. A. Beschin, M. Bilej, E. Torreele, P. De Baetselier, On the existence of cytokines in invertebrates, Cell. Mol. Life Sci. 58 (2001) 801-814.
58. T.M. Clay, A.C. Hobeika, P.J. Mosca, H.K. Lyerly, M.A. Morse, Assays for monitoring cellular immune responses to active immunotherapy of cancer, Clin. Cancer Res. 7 (2001) 1127-1135.
59. J.J. Bleesing, T.A. Fleisher, Cell function-based flow cytometry, Semin. Hematol. 38 (2001) 169-178.
60. C.H. Schein, Producing soluble recombinant RNases and assays to measure their interaction with interferon-γ in vitro, Methods Mol. Biol. 160 (2001) 113-137.
61. R.V. House, Cytokine measurement techniques for assessing hypersensitivity, Toxicology 158 (2001) 51-58.
62. K.M. Mulder, Role of Ras and MAPKs in TGF-β signaling, Cytokine Growth Factor Rev. 11 (2000) 23-35.
63. D. Pennica, W.I. Wood, K.R. Chien, Cardiotrophin-1: a multi-functional cytokine that signals via LIF receptor-gp 130 dependent pathways, Cytokine Growth Factor Rev. 7 (1996) 81-91.
64. C. Ekerfelt, J. Ernerudh, M.C. Jenmalm, Detection of spontaneous and antigen-induced human interleukin-4 responses in vitro: comparison of ELISPOT a novel ELISA and real-time RT-PCR, J. Immunol. Methods 260 (2002) 55-67.
65. L. Neff, M. Zeisel, J. Sibilia, M. Scholler-Guinard, J.P. Klein, D. Wachsmann, NF-κB and the MAP kinases/AP-1 pathways are both involved in interleukin-6 and interleukin-8 expression in fibroblast-like synoviocytes stimulated by protein I/II, a modulin from oral streptococci, Cell. Microbiol. 3 (2001) 703-712.
66. I. Bieche, B. Franc, D. Vidaud, M. Vidaud, R. Lidereau, Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction, Thyroid 11 (2001) 147-152.
67. A. Miyajima, T. Kitamura, N. Harada, T. Yokota, K. Arai, Cytokine receptors and signal transduction, Annu. Rev. Immunol. 10 (1992) 295-331.
68. A. Miyajima, T. Hara, T. Kitamura, Common subunits of cytokine receptors and the functional redundancy of cytokines, Trends Biochem. Sci. 17 (1992) 378-382.
69. T. Miyazaki, M. Maruyama, G. Yamada, M. Hatakeyama, T. Taniguchi, The integrity of the conserved "WS motif" common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction, EMBO J. 10 (1991) 3191-3197.
70. M. Murakami, M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T. Taga, T. Kishimoto, Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family, Proc. Natl. Acad. Sci. USA 88 (1991) 11349-11353.
71. I. Olsson, U. Gullberg, M. Lantz, J. Richter, The receptors for regulatory molecules in hematopoiesis, Eur. J. Hematol. 48 (1992) 1-9.
72. J. Schreurs, D.M. Gorman, A. Miyajima, Cytokine receptors: a new superfamily of receptors, Int. Rev. Cytol. 137B (1992) 121-155.
73. S.R. Sprang, J.F. Bazan, Cytokine structural taxonomy and mechanisms of receptor engagement, Curr. Biol. 3 (1993) 815-818.
74. 2-evoked regulation of HIF-1α and NF-κB in perinatal lung epithelium requires glutathione biosynthesis, Am. J. Physiol. Lung Cell. Mol. Physiol. 278 (2000) L492-L503.
75. J.J. Haddad, S.C. Land, The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-κB (RelA)-selective targeting, Biochem. Biophys. Res. Commun. 271 (2000) 257-267.
76. J.J. Haddad, R.E. Olver, S.C. Land, Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity: evidence for inhibition by glutathione oxidation in alveolar epithelial cells, J. Biol. Chem. 275 (2000) 21130-21139.
77. 2/ROS-dependent release of IL-1β, IL-6 and TNF-α: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium, Cytokine 13 (2001) 138-147.
78. J.J. Haddad, B. Safieh-Garabedian, N.E. Saadé, S.C. Land, Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium, J. Pharmacol. Exp. Therap. 296 (2001) 996-1005.
79. 193-195 receptor antagonism in the alveolar epithelium, Biochem. J. 355 (2001) 29-38.
80. J.J. Haddad, B. Safieh-Garabedian, N.E. Saadé, S.C. Land, The biphasic immunoregulation of pyrimidylpiperazine (Y-40138) is IL-10 sensitive and requires NF-κB targeting in the alveolar epithelium, Br. J. Pharmacol. 133 (2001) 49-60.
81. J.J. Haddad, VX-745: vertex pharmaceuticals, Curr. Opin. Investig. Drugs 2 (2001) 1070-1076.
82. J.J. Haddad, S.C. Land, A non-hypoxic, ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α, FEBS Lett. 505 (2001) 269-274.
83. J.J. Haddad, L-Buthionine-(S,R)-sulfoximine, an irreversible inhibitor of γ-glutamylcysteine synthetase, augments pro-inflammatory cytokine biosynthesis: evidence for the implication of an IκB-α/NF-κB insensitive pathway, Eur. Cytokine Netw. 12 (2001) 614-624.
84. J.J. Haddad, S.C. Land, Amiloride blockades lipopolysaccharide-induced cytokine biosynthesis in an IκB-α/NF-κB-dependent mechanism: evidence for the amplification of an anti-inflammatory pathway in the alveolar epithelium, Am. J. Respir. Cell Mol. Biol. 26 (2002) 114-126.
85. J.J. Haddad, N.E. Saadé, B. Safieh-Garabedian, Redox regulation of TNF-α biosynthesis: augmentation by irreversible inhibition of γ-glutamylcysteine synthetase and the involvement of an IκB-α/NF-κB-independent pathway in alveolar epithelial cells, Cell. Signal. 14 (2001) 211-218.
86. J.J. Haddad, S.C. Land, W.O. Tarnow-Mordi, M. Zembala, D. KowaLczyk, R. Lauterbach, Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated pro-inflammatory cytokine (interleukin-6 and tumor necrosis factor-α) biosynthesis in alveolar epithelial cells, J. Pharmacol. Exp. Therap. 300 (2002) 559-566.
87. J.J. Haddad, S.C. Land, W.O. Tarnow-Mordi, M. Zembala, D. KowaLczyk, R. Lauterbach, Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-κB/nuclear factor-κB-sensitive pathway in alveolar epithelial cells, J. Pharmacol. Exp. Therap. 300 (2002) 567-576.
88. J.J. Haddad, S.C. Land, Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-α biosynthesis, Br. J. Pharmacol. 135 (2002) 520-536.
89. p38-dependent regulation of pro-inflammatory of cytokine production, Biochem. Pharmacol. 63 (2002) 305-320.
90. J.J. Haddad, Recombinant TNF-α mediated regulation of the IκB-α/NF-κB signaling pathway: evidence for the enhancement of pro- and anti-inflammatory cytokines in alveolar epithelial cells, Cytokine 17 (2002) 301-310.
91. J.J. Haddad, Oxygen homeostasis, thiol equilibrium and redox regulation of signaling transcription factors in the alveolar epithelium, Cell. Signal. 14 (2002) 799-810.
92. J.J. Haddad, Recombinant human interleukin (IL)-1β-mediated regulation of hypoxia-inducible factor-1α (HIF-1α) stabilization, nuclear translocation and activation requires an antioxidant/ reactive oxygen species (ROS)-sensitive mechanism, Eur. Cytokine Netw. 13 (2002) 250-260.
93. J.J. Haddad, C.S. Fahlman, Nuclear factor-κB-independent regulation of lipopolysaccharide-mediated interleukin-6 biosynthesis, Biochem. Biophys. Res. Commun. 291 (2002) 1045-1051.
94. J.J. Haddad, Nuclear factor (NF)-κB blockade attenuates but does not abrogate LPS-mediated interleukin (IL)-1β biosynthesis in alveolar epithelial cells, Biochem. Biophys. Res. Commun. 293 (2002) 252-257.
95. J.J. Haddad, Oxygen-sensitive pro-inflammatory cytokines, apoptosis signaling and redox-responsive transcription factors in development and pathophysiology, Cytokines Cell. Mol. Ther. 7 (2001) 1-14.
96. M.M. Ndengele, A.J. Bellone, A.J. Lechner, G.M. Matuschak, Brief hypoxia differentially regulates LPS-induced IL-1 and TNF-α gene transcription in RAW 264.7 cells, Am. J. Physiol. Lung Cell. Mol. Physiol. 278 (2000) L1289-L1296.
97. L.L. Loftis, C.A. Johanns, A.J. Lechner, G.M. Matuschak, Brief hypoxic stress suppresses post-bacteremic NF-κB activation and TNF-α bioactivity in perfused liver, Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000) R99-R108.
98. G.M. Matuschak, K.A. Henry, C.A. Johanns, A.J. Lechner, Liver-lung interactions following Escherichia coli bacteremic sepsis and secondary hepatic ischemia/reperfusion injury, Am. J. Respir. Crit. Care Med. 163 (2001) 1002-1009.
99. J.J. Haddad, Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors, Cell. Signal. 14 (2002) 879-897.